Axon Enterprise’s (AXON) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Axon Enterprise (NASDAQ:AXON – Free Report) in a research note released on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $870.00 price objective on the biotechnology company’s stock. Several other equities analysts have also recently issued reports on the company. JMP Securities […]

Leave a Reply

Your email address will not be published.

Previous post Adobe (NASDAQ:ADBE) Downgraded to Equal Weight Rating by Morgan Stanley
Next post JMP Securities Reiterates Market Outperform Rating for Benitec Biopharma (NASDAQ:BNTC)